DG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/0:0) (BioCAD00000021194)

feces all tissues

Metabolite Card

Formula: C43H74O5 (670.5536)
SMILES: [H][C@](CO)(COC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCCCCCCC\C=C/C\C=C/CCCCC

Synonyms [en]

DG(40:5); DG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/0:0)[iso2]; 1-(9Z,12Z,15Z-octadecatrienoyl)-2-(13Z,16Z-docosadienoyl)-sn-glycerol; (2S)-1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propan-2-yl (13Z,16Z)-docosa-13,16-dienoate; 1-a-Linolenoyl-2-docosadienoyl-sn-glycerol; 1-(9Z,12Z,15Z-Octadeatrienoyl)-2-(13Z,16Z-docosadienoyl)-sn-glycerol

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

DG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/0:0). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000021194). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

DG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/0:0), in particular, consists of one chain of a-linolenic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil, while the docosadienoic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

Entity Information

DBLinks

Other DBLinks
  • PubChem: 9543878
  • HMDB: HMDB0007320
  • LipidMaps: LMGL02010213
  • Metlin: METLIN_4557

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0067236 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0067240 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/24:0)
PathBank:SMP0025719 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0075984 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0075988 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/24:0)
PathBank:SMP0091258 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0091262 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/24:0)
PathBank:SMP0067235 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
PathBank:SMP0067239 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0025718 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0070239 Phosphatidylcholine Biosynthesis PC(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
PathBank:SMP0075983 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
PathBank:SMP0075987 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0082493 Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
PathBank:SMP0087000 Phosphatidylcholine Biosynthesis PC(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
PathBank:SMP0087737 Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
PathBank:SMP0014527 Phosphatidylcholine Biosynthesis PC(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
PathBank:SMP0091257 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
PathBank:SMP0091261 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0015367 Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
View All Pathways